Depression Drugs Market Sales Likely to Surge at Exceptional Rate during Forecast Period, 2018 - 2026
Verfasser: ashwani_kailiya on Friday, 28 June 2019The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report by Fact.MR estimating revenues to decline at a -2% CAGR. According to the study, although the prevalence rate of depression has gone up in the last decade, preference for cognitive behavior therapy (CBT) and awareness about the potential side effects has led to a decline in demand for depression drugs. The study finds that US continued to be at the forefront in terms of total depression drugs sold in 2018.
Ask for Free Sample Report at – https://www.factmr.com/connectus/sample?flag=S&rep_id=3215